?

Free Version

Upgrade subject to access all content

Moderate

RTKs and Cancer Cells

CELLS-PV60T7

Receptor Tyrosine Kinases (RTKs) are a group of cell surface receptors that affect growth, differentiation, migration, and proliferation of some cancer cells.

Some cancer cells with RTKs are susceptible to the binding properties of a protein called Herceptin (HER2), making it a viable cancer treatment course in which of the following cases?

A

The patient's cancer cells have detectable HER2 receptors.

B

The patient's DNA codes for HER2 manufacture.

C

The patient's DNA codes for HER2 receptors.

D

The patient is given oral steroids coupled with HER2.